CN Patent

CN109364066A — 用于治疗多汗症的软性抗胆碱能酯

Assigned to Bodor Laboratories Inc · Expires 2019-02-22 · 7y expired

What this patent protects

具有式(I)的化合物在制备包含大约1.0％至大约25％的所述化合物和可药用载体的药物组合物中的用途： 所述药物组合物用于在就寝前局部给药于哺乳动物受试者的患多汗症区域的皮肤，使得相对于未处理的基准条件，汗液产生至少大约六个(6)小时的至少大约25％的降低。

USPTO Abstract

具有式(I)的化合物在制备包含大约1.0％至大约25％的所述化合物和可药用载体的药物组合物中的用途： 所述药物组合物用于在就寝前局部给药于哺乳动物受试者的患多汗症区域的皮肤，使得相对于未处理的基准条件，汗液产生至少大约六个(6)小时的至少大约25％的降低。

Drugs covered by this patent

Patent Metadata

Patent number
CN109364066A
Jurisdiction
CN
Classification
—
Expires
2019-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Bodor Laboratories Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.